Treatment With Dinutuximab, Sargramostim (GM-CSF), and Isotretinoin in Combination With Irinotecan and Temozolomide After Intensive Therapy for People With High-Risk Neuroblastoma (NBL)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Temozolomide
Related studies linked through entity extraction aliases.
Pilot Study of B7-H3 CAR-T in Treating Patients With Recurrent and Refractory Glioblastoma
- Status
- UNKNOWN
- Phase
- PHASE1
NG101m Adjuvant Therapy in Glioblastoma Patients
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Flavored, Oral Irinotecan VAL-413 (Orotecan®) Given With Temozolomide for Treatment of Recurrent Pediatric Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of CC-90010 in Combination With Temozolomide With or Without Radiation Therapy in Participants With Newly Diagnosed Glioblastoma
- Status
- TERMINATED
- Phase
- PHASE1
Radiotherapy Versus Radiotherapy Combined With Temozolomide in High-risk Low-grade Gliomas After Surgery
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Anticancer Therapeutic Vaccination Using Telomerase-derived Universal Cancer Peptides in Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE2
Nivolumab in Combination With Temozolomide and Radiotherapy in Children and Adolescents With Newly Diagnosed High-grade Glioma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
9-ING-41 in Pediatric Patients With Refractory Malignancies.
- Status
- TERMINATED
- Phase
- PHASE1
A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Selinexor (KPT-330) in Combination With Temozolomide and Radiation Therapy in Patients With Newly Diagnosed Glioblastoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Cabozantinib and Temozolomide for the Treatment of Unresectable or Metastatic Leiomyosarcoma or Other Soft Tissue Sarcoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Recurrent Sarcoma
- Status
- RECRUITING
- Phase
- NA
Nivolumab and Temozolomide Versus Temozolomide Alone in Newly Diagnosed Elderly Patients With GBM
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of Tislelizumab, Pamiparib, and Other Investigational Agents in Participants With Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE3
Addition of Anlotinib Hydrochloride to the Stupp Regimen Versus the Stupp Regimen Alone for Newly Diagnosed Glioblastoma
- Status
- UNKNOWN
- Phase
- PHASE2
Temozolomide for Second-Line Treatment of Neuroendocrine Carcinomas
- Status
- COMPLETED
- Phase
- PHASE2
Testing the Addition of an Anti-cancer Viral Gene Therapy, Toca 511/Toca FC, to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed Glioblastoma
- Status
- WITHDRAWN
- Phase
- PHASE2/PHASE3
B7-H3 CAR-T for Recurrent or Refractory Glioblastoma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2